Embolización selectiva de las arterias uterinas en el tratamiento de miomas sintomáticos: dos años de seguimiento

Abstract

Listen

Translate article

Leiomyoma is the most common gynecologic tumor. Uterine artery embolization (UAE) is used as an alternative to myomectomy or hysterectomy to treat uterine leiomyoma. Objective To determinate the epidemiological and clinical characteristics of patients undergoing UAE and to analyze the results of UAE at 2 years. Material and methods An observational, descriptive study was carried out in 93 patients who underwent UAE for the treatment of uterine myoma. A complete history and physical examination were performed and laboratory data were collected. Follow-up visits were performed at 2, 6, 12 and 24 months after the procedure. Results The mean number of days of bleeding was 6.74 (4–14). The mean hemoglobin was 11.94 g/dl (7–16). The mean length of hospital stay was 4.2 days (2–10), and the number of subsequent days of pain was 5.8 (1–15). There were three cases of transient amenorrhea (3.2%) and three of permanent amenorrhea (3.2%). The volume and size of uterine myoma were significantly reduced at each follow-up visit until 2 years after the embolization. A significant decrease in symptoms, bleeding and pain was confirmed in this period. Discussion UAE is a well-tolerated and effective technique, with a statistically significant response of all clinical and ultrasonographic parameters. The indications for UAE should be clearly defined and followed to maintain the efficacy and utility of this procedure.